Normal view MARC view ISBD view

The Antibody underdog : Regeneron made headlines but Eli Lilly bets its covid drug can help more patients faster.

Publisher: Bloomberg Businessweek. Nov. 2020Description: Iss. 4676 : pg 1-3.ISSN: 0007-7135.Subject(s): Business planning

Tags from this library: No tags from this library for this title. Log in to add tags.

average rating: 0.0 (0 votes)

Item type	Home library	Collection	Call number	Copy number	Status	Date due	Barcode	Item holds
Periodicals	College Library	Periodicals	PER HB E455 2020 (Browse shelf)	1	Not for loan

Total holds: 0

Previous	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	Next
Previous	PER HB E364 2021 The Race to mars!	PER HB E364 2021 Taking the travel out of duty free.	PER HB E378 2020 The Customer is king again : travel may not come back bigger, but it will be better.	PER HB E455 2020 The Antibody underdog : Regeneron made headlines but Eli Lilly bets its covid drug can help more patients faster.	PER HB E455 2020 The Window is closing on vaccine makers.	PER HB E455 2021 Can Astrazeneca heal itself? : Shortages, unclear trial data, and question about efficacy have slowed the rollout of the company's vaccine in Europe.	PER HB E455 2021 Can Aluminum really go green?	Next

There are no comments for this item.